Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.
Phase 2
Withdrawn
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Combination Product: Placebo + Cetuximab + FOLFIRI
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- SFJ Pharmaceuticals X, LTD.
- Registration Number
- NCT03688230
News
No news found